NOD2 deficiency confers a pro‐tumorigenic macrophage phenotype to promote lung adenocarcinoma progression

Journal of Cellular and Molecular Medicine

Bo Li¹  Ziwei Miao¹  Xiaoxue Qin¹  Yun Han²  Yibei Wang³ 

[1] Department of Developmental Cell Biology, Key Laboratory of Medical Cell Biology, Ministry of Education, China Medical University, Shenyang, China;Department of Thoracic Surgery, Shengjing Hospital of China Medical University, Shenyang, China;Department of Thoracic Surgery, Shengjing Hospital of China Medical University, Shenyang, China;Department of Developmental Cell Biology, Key Laboratory of Medical Cell Biology, Ministry of Education, China Medical University, Shenyang, China;

关键词: immunotherapy;    lung adenocarcinoma;    NOD2;    tumour immune microenvironment;    tumour‐associated macrophages;   

DOI  :  10.1111/jcmm.16790

来源: Wiley

【 授权许可】

CC BY